The findings suggest that temporal long-term increases of hs-cTn levels are associated with higher risks of adverse cardiovascular outcomes in the future,14 15 and that a lowering of hs-cTnT concentrations may conversely reduce these risks.16 However, whether repeated hs-cTn measurement over time could be used to improve the ability of clinicians to identify individuals who are at high risk of cardiovascular disease, or to monitor or modify this risk, is unknown. Here, TNNT2 is linked to cardiovascular disorder.